Lactoferricin B-derived peptides inhibited endothelin-converting enzyme (ECE)-dependent vasoconstriction, adding blood pressure regulation through endothelin pathway to antimicrobial and ACE-inhibitory activities — triple cardiovascular function.
Key findingLactoferricin B-derived peptides inhibited endothelin-converting enzyme (ECE)-dependent vasoconstriction, adding blood pressure regulation through end
What the researchers found
Lactoferricin B-derived peptides inhibited endothelin-converting enzyme (ECE)-dependent vasoconstriction, adding blood pressure regulation through endothelin pathway to antimicrobial and ACE-inhibitory activities — triple cardiovascular function.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Lactoferricin B-derived peptides with inhibitory effects on ECE-dependent vasoconstriction.
Peptides, 31(10), 1926-33
Citation
Fernández-Musoles, Ricardo; López-Díez, José Javier; Torregrosa, Germán; Vallés, Salvador; Alborch, Enrique; Manzanares, Paloma; Salom, Juan B. (2010). Lactoferricin B-derived peptides with inhibitory effects on ECE-dependent vasoconstriction.. Peptides, 31(10), 1926-33. https://doi.org/10.1016/j.peptides.2010.06.024